Leptin in nonalcoholic fatty liver disease
Journal Title: Annals of Hepatology - Year 2008, Vol 7, Issue 3
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In this study, we aimed to examine whether serum leptin levels correlate with insulin resistance, oxidative stress parameters and the severity of histological changes in NAFLD. Methods: Fifty-two patients (M/F: 28/24) with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied. Serum leptin levels were measured by radioimmunoassay. HOMA (homeostasis model assessment) IR index was calculated. Comparisons between the patients with NAFLD and non-alcoholic steatohepatitis (NASH) were performed using the Student’s t test. Multivariate regression analysis and the area under the receiver operating characteristic (ROC) curve were used to identify the independent predictors for NASH. Results: We found no association between serum leptin, fasting insulin levels, and oxidative stress parameters. ROC curve and multiple regression analysis revealed no association between the severity of histological changes and serum leptin levels. During six months followed-up period only NASH group with elevated leptin levels had significant reductions of ALT and AST values (p = 0.03, and 0.005, respectively). Conclusion: Our findings show a preventive effect of leptin against progressive liver injury in NAFLD.
Authors and Affiliations
Billur Canbakan, Veysel Tahan, Huriye Balci, Ibrahim Hatemi, Burak Erer, Gulsen Ozbay, Necdet Sut, Munire Hacibekiroglu, Nese Imeryuz, Hakan Senturk
Keywords
Related Articles
- EP ID EP77797
- DOI -
- Views 139
- Downloads 0
Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is...
Annals Impact Factor 1.67. Welcome to the IF club: achievement and challeng
Alcohol, liver and genes: an intricate puzzle
Insulin resistance and steatosis in chronic hepatitis C
In chronic hepatitis C, insulin resistance (IR) and type 2 diabetes mellitus (DM) are more prevalent than in healthy controls or in chronic hepatitis B patients. HCV infection promotes IR mainly through increased TNF-a a...
Does the size of the needle influence the number of portal tracts obtained through percutaneous liver biopsy?
Aim. Liver biopsy (LB) is often essential for the diagnosis and staging of chronic viral hepatitis. The aim of our paper was to establish if the size of the biopsy needle influences the number of portal tracts obtained...